Diffuse large B-cell lymphoma

Six-month analysis of tisagenlecleucel shows sustained responses

Jatros Digital, 28.11.2017
Hämatologie | Onkologie

Stephen J. Schuster, MD, University of Pennsylvania, presents the primary analysis of JULIET: a global pivotal phase-II-trial of CTL019 in adult patients with relapsed or refractory diffuse large B-cell lymphoma.

zurück zum ASH Newsroom 2017